COX-2 and EGFR: Partners in Crime Split by Aspirin
Main Authors: | Paola Patrignani, Melania Dovizio |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-05-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396415001073 |
Similar Items
-
Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent
by: Paola Patrignani, et al.
Published: (2012-12-01) -
Time for Integrating Clinical, Lifestyle and Molecular Data to Predict Drug Responses
by: Paola Patrignani, et al.
Published: (2016-05-01) -
P2Y12 Receptors in Tumorigenesis and Metastasis
by: Patrizia Ballerini, et al.
Published: (2018-02-01) -
Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients
by: Angel Lanas, et al.
Published: (2023-04-01) -
In Silico Investigation of Some Glucose-Aspirin as COX Inhibitor
by: Md. Atiquel Islam Chowdhury, et al.
Published: (2022-04-01)